Pep2tango Therapeutics

Pep2Tango Therapeutics is a biotech company developing superior unimolecular multi-receptor agonists for obesity and related disorders. Their lead program in obesity is a first-in-class tetra-receptor peptide agonist peptide that shows superiority to Tirzepatide for weight loss in obesity animal models. Other key product differentiation attributes include selective weight loss from fat mass with preservation of lean mass / muscle. With their cutting-edge peptide platform and promising pipeline, Pep2Tango aims to revolutionize obesity and metabolic disease treatment with better, safer, and more effective therapies.